Vanguard Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.96M | Sell |
3,627,510
-13,838
| -0.4% | -$34.2K | ﹤0.01% | 2962 |
|
|
2025
Q1 | $7.25M | Sell |
3,641,348
-13,969
| -0.4% | -$27.8K | ﹤0.01% | 3022 |
|
|
2024
Q4 | $10.7M | Sell |
3,655,317
-1,234,996
| -25% | -$3.61M | ﹤0.01% | 2918 |
|
|
2024
Q3 | $18.9M | Sell |
4,890,313
-1,188,540
| -20% | -$4.6M | ﹤0.01% | 2613 |
|
|
2024
Q2 | $31.2M | Buy |
6,078,853
+277,408
| +5% | +$1.43M | ﹤0.01% | 2348 |
|
|
2024
Q1 | $40.6M | Buy |
5,801,445
+1,746,534
| +43% | +$12.2M | ﹤0.01% | 2258 |
|
|
2023
Q4 | $35.9M | Buy |
4,054,911
+103,118
| +3% | +$914K | ﹤0.01% | 2324 |
|
|
2023
Q3 | $37.7M | Buy |
3,951,793
+617,310
| +19% | +$5.89M | ﹤0.01% | 2262 |
|
|
2023
Q2 | $48.9M | Buy |
3,334,483
+2,450,037
| +277% | +$35.9M | ﹤0.01% | 2192 |
|
|
2023
Q1 | $10.9M | Buy |
884,446
+11,923
| +1% | +$147K | ﹤0.01% | 2887 |
|
|
2022
Q4 | $16.2M | Buy |
+872,523
| New | +$16.2M | ﹤0.01% | 2723 |
|